Literature DB >> 7057184

Choline uptake in cultured human Y79 retinoblastoma cells: effect of polyunsaturated fatty acid compositional modifications.

B T Hyman, A A Spector.   

Abstract

Choline uptake in Y79 human retinoblastoma cells occurs through two kinetically distinguishable processes. The high-affinity system shows little sodium or energy dependence, and it does not appear to be linked to acetyl CoA; choline O-acetyltransferase. When the cells are grown in a culture medium containing 10% fetal bovine serum, the high-affinity system has a K'm= 2.16 +/- 0.13 microM and V'max = 27.0 +/- 2.9 pmol min-1 mg-1, whereas the low-affinity system has a k'm = 20.4 +/- 1.3 microM and V'max = 402 +/- 49 pmol min-1 mg-1. Under these conditions, the polyunsaturated fatty acid content of the cell membranes is relatively low. When the polyunsaturated fatty acid content of the microsomal membrane fraction was increased by supplementing the culture medium with linolenic or docosahexaenoic acids (n-3 polyunsaturated fatty acids) or arachidonic acid (n-6 polyunsaturated fatty acid), the K'm of the high-affinity choline transport system was reduced by 40--60%. The V'max also was reduced by 20--40%. Supplementation with oleic acid, the most prevalent monounsaturated fatty acid, did not affect either kinetic parameter. The results suggest that one functional effect of the high unsaturated fatty acid content of neural cell membranes is to facilitate the capacity of the high-affinity choline uptake system to transport low concentrations of choline. This effect appears to be specific for polyunsaturated fatty acids but not for a single type, for it is produced by members of both the n-3 and n-6 classes of polyunsaturated fatty acids.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7057184     DOI: 10.1111/j.1471-4159.1982.tb08680.x

Source DB:  PubMed          Journal:  J Neurochem        ISSN: 0022-3042            Impact factor:   5.372


  9 in total

Review 1.  Essentiality of fatty acids.

Authors:  A A Spector
Journal:  Lipids       Date:  1999       Impact factor: 1.880

Review 2.  Excitable membranes, lipid messengers, and immediate-early genes. Alteration of signal transduction in neuromodulation and neurotrauma.

Authors:  J P Doucet; N G Bazan
Journal:  Mol Neurobiol       Date:  1992       Impact factor: 5.590

3.  Modification of the fatty acid composition of L1210 leukemia subcellular organelles.

Authors:  C P Burns; J A North; C J Mossman; L M Ingraham
Journal:  Lipids       Date:  1988-06       Impact factor: 1.880

4.  The effects of exposure to exogenous fatty acids and membrane fatty acid modification on the electrical properties of NG108-15 cells.

Authors:  J A Love; W R Saum; R McGee
Journal:  Cell Mol Neurobiol       Date:  1985-12       Impact factor: 5.046

5.  Membrane lipid alteration: effect on cellular uptake of mitoxantrone.

Authors:  C P Burns; B N Haugstad; C J Mossman; J A North; L M Ingraham
Journal:  Lipids       Date:  1988-05       Impact factor: 1.880

6.  Membrane fatty acid modification in tumor cells: a potential therapeutic adjunct.

Authors:  C P Burns; A A Spector
Journal:  Lipids       Date:  1987-03       Impact factor: 1.880

7.  Stimulus-specific induction of phospholipid and arachidonic acid metabolism in human neutrophils.

Authors:  R W Godfrey; R M Manzi; M A Clark; S T Hoffstein
Journal:  J Cell Biol       Date:  1987-04       Impact factor: 10.539

8.  Colorimetric and longitudinal analysis of leukocoria in recreational photographs of children with retinoblastoma.

Authors:  Alireza Abdolvahabi; Brandon W Taylor; Rebecca L Holden; Elizabeth V Shaw; Alex Kentsis; Carlos Rodriguez-Galindo; Shizuo Mukai; Bryan F Shaw
Journal:  PLoS One       Date:  2013-10-30       Impact factor: 3.240

Review 9.  Choline and docosahexaenoic acid during the first 1000 days and children's health and development in low- and middle-income countries.

Authors:  Megan G Bragg; Elizabeth L Prado; Christine P Stewart
Journal:  Nutr Rev       Date:  2022-03-10       Impact factor: 7.110

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.